SmartSleep Device for Adolescent PTSD
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to characterize the role of sleep, emotion processing, and daily affect in post-traumatic stress disorder (PTSD) and whether improving sleep quality using slow wave activity enhancement will impact next-day affect in youth. Participants will attend 4 study visits: * A clinical and trauma assessment visit * A testing day that may include cognitive testing, surveys, and an MRI. * An overnight sleep study following one week of at-home sleep recordings with the device in the sham condition * An overnight sleep study following one week of at-home sleep recordings with the device in the sleep enhancement condition
Will I have to stop taking my current medications?
The trial requires that participants do not use medications or other drugs in a way that might interfere with sleep. If your current medications affect your sleep, you may need to stop or adjust them.
What data supports the effectiveness of the SmartSleep device treatment for adolescent PTSD?
Research shows that sleep therapies, like cognitive behavioral therapy for insomnia, have been effective in treating sleep issues related to PTSD. Additionally, treatments for sleep disorders often lead to improvements in PTSD symptoms, suggesting that addressing sleep disturbances can be beneficial for managing PTSD.12345
How does the SmartSleep Device treatment for adolescent PTSD differ from other treatments?
The SmartSleep Device is unique because it focuses on improving sleep disturbances, which are common in PTSD, by using a specialized device to potentially reduce symptoms like nightmares and sleep disruptions. Unlike traditional therapies that may not specifically target sleep issues, this device offers a novel approach by addressing a critical aspect of PTSD that can worsen other symptoms.14567
Research Team
Stephanie Jones, MD, PhD
Principal Investigator
University of Wisconsin, Madison
Eligibility Criteria
This trial is for adolescents who have PTSD. They must be able to attend four study visits, including assessments, cognitive tests, surveys, an MRI scan, and two overnight sleep studies after a week of at-home sleep recordings.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Clinical and Trauma Assessment
Participants undergo a clinical and trauma assessment
Testing
Participants complete cognitive testing, surveys, and an MRI
Sham Condition Sleep Study
Participants complete an overnight sleep study following one week of at-home sleep recordings with the device in the sham condition
Sleep Enhancement Condition Sleep Study
Participants complete an overnight sleep study following one week of at-home sleep recordings with the device in the sleep enhancement condition
Follow-up
Participants are monitored for changes in emotional regulation and sleep activity
Treatment Details
Interventions
- SmartSleep device (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
Robert Drape
University of Wisconsin, Madison
Chief Executive Officer since 2007
Executive MBA from the University of Wisconsin – Madison, Bachelor's degree in Biology from Augustana College (IL)
Dr. Ciara Barclay-Buchanan
University of Wisconsin, Madison
Chief Medical Officer since 2023
MD from Wayne State University School of Medicine
National Institute of Mental Health (NIMH)
Collaborator
Dr. Joshua A. Gordon
National Institute of Mental Health (NIMH)
Chief Executive Officer since 2016
MD, PhD
Dr. Shelli Avenevoli
National Institute of Mental Health (NIMH)
Chief Medical Officer
PhD